• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[某大学医院成人百日咳博德特氏菌血清阳性率调查]

[Investigation of seropositivity of Bordetella pertussis in adults in a university hospital].

作者信息

Öksüz Lütfiye, Gürler Nezahat, Ağaçfidan Ali

机构信息

İstanbul University Istanbul Faculty of Medicine, Department of Medical Microbiology, Istanbul, Turkey.

出版信息

Mikrobiyol Bul. 2017 Jan;51(1):62-72. doi: 10.5578/mb.46533.

DOI:10.5578/mb.46533
PMID:28283011
Abstract

Whooping cough is a vaccine-preventable infectious diseases caused by Bordetella pertussis/parapertussis. Despite of routine immunization programs in the world, pertussis still remains endemic. Recently unvaccinated or partially immunized infants have infected with this pathogen and also increase of incidence was observed in adolescents and adults. The source of pertussis in newborns are attributed to household, especially due to the family members. Theaim of this study was to determine B.pertussis IgG antibody positivity by ELISA method in adults. Eighty-four of the total study population (39.6%) were anti-pertussis IgG positive, 128 (60.4%) were negative. The samples included in the study (n= 212) were divided into three groups according to ages: 19-35 years (Group 1, n= 61), 36-50 years (Group 2, n= 58), 51-65 years (Group 3, n= 93). Anti-pertussis IgG antibody positivity was 26.2% (n= 22) in Group 1, 26.2% (n= 22) in Group 2 and 47.6% (n= 40) in Group 3. According to the anti-pertussis IgG positivity results, no significant difference was observed between genders. The results were obtained as absorbance values by ELISA test, then transformed into semi-quantitative values as NovaTec Test Unit (NTU). NTU positive values were between 11.01-39.4. Ninety four percent of NTU values were in the range of 11.01 to 28.01 and 6% were between 28.01 to 39.4. It was observed that seropositivity rates peaked at ages of 27, 55 and 65. The highest NTU values were observed in the age of 32 in females and in the age of 24 in males. Relatively, low seropositivity values (NT= 15-20) were observed in both females and males to the age of 45 in Group 2. However a slight increase was observed in females after the age of 45. An increase (NTU ≥ 20) was determined in the age of 49 in males. The seropositivity rates were generally low (NT ≤ 20) in females in Group 3, but the highest values (NTU ≥ 30) were observed in 55 and 65 years of age in males in this group. The highest seropositivity (NTI ≥ 30) were in 55 and 65 years of age (NTI ≥ 30) in males and 27 years of age (NTU ≥ 30) in females while in 36-50 age range, it was relatively low (NTI ≤ 20). Routine pertussis vaccination program is not yet implemented for adults in our country. However, the causes more clearly demonstrate the need for adult pertussis vaccination since adults may be incompletely vaccinated or not vaccinated in the childhood, current vaccinations are not available in the childhood of adults, adults become more susceptible to infections as the age increases, life expectancy increases and the likelihood of encountering infections, and childhood vaccination antibodies diminish over time. According to the results of this study, a single dose of pertussis vaccine is recommended to implement for adults in our country.

摘要

百日咳是一种由百日咳博德特氏菌/副百日咳博德特氏菌引起的可通过疫苗预防的传染病。尽管全球都有常规免疫计划,但百日咳仍然流行。最近,未接种疫苗或部分免疫的婴儿感染了这种病原体,并且在青少年和成年人中也观察到发病率上升。新生儿百日咳的传染源归因于家庭,尤其是家庭成员。本研究的目的是通过酶联免疫吸附测定(ELISA)法测定成年人中百日咳博德特氏菌IgG抗体的阳性率。在研究总人口中,84人(39.6%)抗百日咳IgG呈阳性,128人(60.4%)呈阴性。纳入研究的样本(n = 212)根据年龄分为三组:19 - 35岁(第1组,n = 61)、36 - 50岁(第2组,n = 58)、51 - 65岁(第3组,n = 93)。第1组抗百日咳IgG抗体阳性率为26.2%(n = 22),第2组为26.2%(n = 22),第3组为47.6%(n = 40)。根据抗百日咳IgG阳性结果,未观察到性别之间存在显著差异。通过ELISA试验获得的结果以吸光度值表示,然后转换为半定量值,即诺华测试单位(NTU)。NTU阳性值在11.01 - 39.4之间。94%的NTU值在11.01至28.01范围内,6%在28.01至39.4之间。观察到血清阳性率在27岁、55岁和65岁时达到峰值。女性在32岁时观察到最高NTU值,男性在24岁时观察到最高NTU值。相对而言,在第2组中,45岁之前的女性和男性血清阳性值(NT = 15 - 20)都较低。然而,45岁之后女性略有上升。男性在49岁时出现上升(NTU≥20)。第3组中女性的血清阳性率总体较低(NT≤20),但该组中男性在55岁和65岁时观察到最高值(NTU≥30)。最高血清阳性率(NTI≥30)在男性55岁和65岁时以及女性27岁时出现,而在36 - 50岁年龄范围内相对较低(NTI≤20)。我国尚未对成年人实施常规百日咳疫苗接种计划。然而,这些原因更清楚地表明了成年人接种百日咳疫苗的必要性,因为成年人在儿童时期可能未完全接种或未接种疫苗,成年人儿童时期没有现有的疫苗接种,随着年龄增长成年人更容易感染,预期寿命增加且接触感染的可能性增加,并且儿童时期接种疫苗产生的抗体随时间会减少。根据本研究结果,建议在我国为成年人接种一剂百日咳疫苗。

相似文献

1
[Investigation of seropositivity of Bordetella pertussis in adults in a university hospital].[某大学医院成人百日咳博德特氏菌血清阳性率调查]
Mikrobiyol Bul. 2017 Jan;51(1):62-72. doi: 10.5578/mb.46533.
2
[Seroepidemiology of pertussis in 10-15 years old healthy children in Isparta province, Turkey].[土耳其伊斯帕尔塔省10至15岁健康儿童百日咳血清流行病学研究]
Mikrobiyol Bul. 2013 Jul;47(3):507-13. doi: 10.5578/mb.5598.
3
[Serological evaluation of Bordetella pertussis infection in adults with prolonged cough].[成人持续性咳嗽患者百日咳博德特氏菌感染的血清学评估]
Mikrobiyol Bul. 2016 Jul;50(3):361-70. doi: 10.5578/mb.27692.
4
[Pertussis seroprevalence and vaccination status in three selected provinces of Turkey].[土耳其三个选定省份的百日咳血清流行率和疫苗接种状况]
Mikrobiyol Bul. 2008 Jul;42(3):389-98.
5
Seroprevalence of Bordetella pertussis specific Immunoglobulin G antibody levels among asymptomatic individuals aged 4 to 24 years: a descriptive cross sectional study from Sri Lanka.4至24岁无症状个体中百日咳博德特氏菌特异性免疫球蛋白G抗体水平的血清流行率:一项来自斯里兰卡的描述性横断面研究。
BMC Infect Dis. 2016 Dec 1;16(1):729. doi: 10.1186/s12879-016-2068-z.
6
Seroprevalence of Bordetella pertussis immunoglobulin G antibodies among children in Samsun, Turkey.土耳其萨姆松儿童中百日咳博德特氏菌免疫球蛋白G抗体的血清流行率。
Turk J Pediatr. 2012 Jan-Feb;54(1):15-9.
7
Sustained efficacy during the first 6 years of life of 3-component acellular pertussis vaccines administered in infancy: the Italian experience.婴儿期接种的三组分无细胞百日咳疫苗在生命最初6年的持续效力:意大利的经验。
Pediatrics. 2001 Nov;108(5):E81. doi: 10.1542/peds.108.5.e81.
8
[Seroprevalence of pertussis toxin antibody in Manisa province of Turkey, after six years implementation of acellular pertussis vaccine].[在土耳其马尼萨省实施无细胞百日咳疫苗六年之后百日咳毒素抗体的血清流行率]
Mikrobiyol Bul. 2018 Apr;52(2):180-189. doi: 10.5578/mb.57534.
9
Re-emergence of pertussis: what are the solutions?百日咳再现:有何应对之策?
Expert Rev Vaccines. 2012 Nov;11(11):1331-46. doi: 10.1586/erv.12.118.
10
Should fimbriae be included in pertussis vaccines? Studies on ELISA IgG anti-Fim2/3 antibodies after vaccination and infection.百日咳疫苗中应包含菌毛吗?接种疫苗和感染后ELISA法检测IgG抗Fim2/3抗体的研究。
APMIS. 2009 Sep;117(9):660-71. doi: 10.1111/j.1600-0463.2009.02521.x.

引用本文的文献

1
The Present and Future Aspects of Life-Long Pertussis Prevention: Narrative Review with Regional Perspectives for Türkiye.终身预防百日咳的现状与未来展望:基于土耳其地区视角的叙述性综述
Infect Dis Ther. 2023 Nov;12(11):2495-2512. doi: 10.1007/s40121-023-00876-0. Epub 2023 Oct 10.